EMD Serono Inc., Merck KGaA’s North American drug development business, has officially taken up residence in Boston’s Seaport ...

Shares of Summit Therapeutics, whose cancer drug candidate turned heads after it outperformed a blockbuster drug from Merck, ...

Finally, Merck is hosting a series of science competitions ... It operates out of four locations with headquarters in Amsterdam (The Netherlands), and has offices in Darmstadt (Germany), Boston ...

The newly designed and constructed building at the heart of Merck headquarters offers start-ups and company-internal innovation teams a five times larger area than was formerly available for ...

A U.S. appeals court on Friday revived more than 500 lawsuits alleging that Merck & Co failed to warn that its osteoporosis ...

Merck, as a leading science and technology ... It operates out of four locations with headquarters in Amsterdam (The Netherlands), and has offices in Darmstadt (Germany), Boston (United States ...

Daiichi Sankyo and Merck said on Tuesday that their drug, patritumab deruxtecan, met the main goal of extending the time some ...

Fintel reports that on September 6, 2024, JP Morgan downgraded their outlook for Organon (NYSE:OGN) from Neutral to ...

In August 2023, the U.S. Department of Health and Human Services announced the first 10 drugs covered under Medicare Part D ...

Forbes Business constructed a list of the Best Employers by state in 2024. New Jersey's list of top employers featured 90 companies.

IDEAYA Biosciences is a promising biotech company targeting genetic vulnerabilities in cancer cells with synthetic lethality.